Downloading...
Download

Swedish

Swedbank Just Did Something It Hasn't Done in 18 Years!Hi all, A few weeks ago, at the Estonian finance conference, I pointed out that Swedbank needs a Monthly candle close above a historically significant level to confirm further upside into "open waters". Before I dive deeper - if someone still claims that "price has no history" or "price doesn't repeat itself," just show them Swedbank’s chart. Back in 2007, Swedbank attempted to break the 215–228 SEK level for the first time. The result? A complete failure. Sellers took control and smashed the price down. Fast forward 7–10 years: “Let’s try again a few more times!” Still nothing. The level remained unbreakable, draining all momentum. Over the past 18 years, this zone has been tested 7–9 times, and every single attempt ended in failure. Now, today, things are changed. Today, we have that Monthly close, and the price has now entered a potential buying zone. Technically, Swedbank is ready - optimal zone 215 to 237 SEK! Do your homework; this is just my opinion and my analysis! Do not forget to "Boost" the idea - all the best, Vaido
OMXSTO:SWED_ALong
by VaidoVeek
5
RakeTech in upward trendRakeTech will likely follow an upwards short-term trend. Be aware that RakeTech has a low volume and small market Cap, making it rather risky. The stock has experienced a golden cross in August 2020, and has been climbing nicely in the trend channel since. Shortly in November the upper bound was tested, and the price lowered to the limit of the lower bound. This movement was resisted by a support level in 10.30. The price is now heading towards the price gap experienced in November 2019, with a rising RSI, whereby the price might break above 11.85 and go for 13.05.
OMXSTO:RAKELong
by PersonalFinanceDude
Long Position MekonomenSeems to be an increasing/supportive trend, which has broken through the temporary resistance barrier in 83.9 SEK. The increasing trend is happening 'despite' moderate RSI level. A potential golden cross might appear within 2 weeks, as short (14) avg. seems to firstly balance and later overtake long (200) avg. First downward bounce in trend stream might be 95.6 SEK, as this is a possible resistance point. The previous Barrier area: 82.5-83.9; this should be stop loss. OMXSTO:MEKO
OMXSTO:MEKOLong
by UnknownUnicorn4622096
ridethepig | Remaining Short EURSEK A timely update to the EURSEK chart with 2020 flows entering into play as widely anticipated. Lets start by reviewing the concerning Macro Map in the diagram: In the longer term, positional swings come down to a struggle between patience on the one hand and greed tendencies on the other. In this all-encompassing battle, economic strategy, though important in itself, will always need the presence of technicals in order to strive for mobility. I am expecting sooner or later the free-fall to begin and get rid of the early dip buyers. Good luck all those on the sell side. As usual thanks for keeping your support coming with likes, comments and etc!
Short
by ridethepig
ridethepig | SEK Long-Term Macro Map📍 USDSEK Long Term Macro Map After the " Moment of Truth for SEK " flow, which was so difficult with its own inherent positional issues, the next update here should appear all too straightforward again. Of course a well planned macro flow does not have to last forever; a dollar devaluation swing which only crops up occasionally, in fact can even threaten the 6.80x support. Some 8 candles later, the flows are following the widely mapped positional forecast. This swing has the clear fundamental advantage from the soft inherent picture in Sweden. Things have not settled down on the virus front which has become quite forgotten by many. Then of course when a second wave occurs in the Northern Hemisphere during the Winter months, the almost forgotten complacency will return, bringing a zig-zag into the initial forecast into the initial 8.20x target. Dollar seller's last move sees the impulsive swing being instated, for the threat is now the clear advance onto the main targets. It is therefore logically and casually relevant to all G10 crosses to include the DXY maps: At the point when this was made, Fed was seen as a deer in the headlights via Covid capitulation / flip flop and, with what immense trouble they will have now in achieving credibility after funding the Whitehouse policies in broad daylight!! Watch for the lows next week, its not quite so easy for buyers to dispose of the momentum here: if this happens we may enter into waterfall mode.
Short
by ridethepig
Triangle formation near apex. Break up gives buy signalBonesupport reported some very promising results in the latest report, but the market has not yet, in my opinion, realised its value. It actually gave no effect at all on the stock. ABG sundal Collier recently raised the target price to 53kr from 30kr. ABG Sundal Collier höjer riktkursen för Bonesupport till 53 kronor från 30 kronor. Rekommendationen köp upprepas. Det framgår av en analys. Carnegie is acting as sell block at the moment but when they loosen their sell pressure, the revaluation can begin. A triangle formation with a raising introduction is getting closer to its apex and if the stock breaks the triangle roof, a price of 46kr is justified. Overall there is both technical and fundamental support at this level (30kr-35kr) and is in my opinion undervalued. --- This is not a recommendation, but rather my speculations and personal thoughts. You should always make your own analysis before buying any stock. ---
OMXSTO:BONEXLong
by EXLUSIVOO
Xbrane moving out of DowntrendXbrane Biopharma AB is a biotechnology company which develops and manufactures biosimilars. Xbrane has a patented protein production platform and world-leading expertise within biosimilar development. Xbrane’s headquarter is located in Solna, just outside of Stockholm, and the company has research and development facilities in Sweden and in Italy. Biosimilars are approved pharmaceuticals that are similar to a biological reference product in terms of quality, safety and efficacy. They are approved in highly regulated markets such as the EU and the US. Biosimilars are so far typically launched with a 20-40% discount vs. the reference biological drug improving significantly the accessibility of the treatments and generating massive cost savings for private and public payors. Xlucane - Lucentis® - Phase 3 - Global annual sales € 3.2 billion phase III trial was initiated Q1 2019 with primary aim to evaluate comparative efficacy in terms of change in visual acuity 8 weeks after initiation of treatment. Xbrane has acceptance for the study design from both EMA and FDA. The target is to launch the product upon patent expiration in Europe beginning of 2022. Preclinical drugs Spherotide - Decapeptyl® Xcimzane - Cimzia® - Global annual sales € 1.4 billion Xoncane - Oncaspar® Xbrane has entered into a co-development agreement for Xlucane with the German generic/biosimilar company STADA. Under the agreement Xbrane is responsible for development of the product and STADA for sales and marketing. Development expenses and profits generated from sales of the product are shared 50/50.
OMXSTO:XBRANELong
by Charlestrad3r
USDSEKUSDSEK has been showing some nice support at some key zones. Though I'm in for a long at the monthly S1, if the trade works out I'm probably early so there should be another chance to enter - if you think USD has some overall strength still to show. Reason for the expectation that there will be another entry - their CB will be on deck next week. They have widely telegraphed that they will tighten at this meeting - and that has been the main reason for SEK strength in the last few months. We should expect continued SEK strength into the meeting unless the USD side of the equation strengthens considerably. However, looking beyond that, they have already said that they expect rates to stand pat for a considerable length of time after this raise - so unless they change this narrative, there should be a bounce for USDSEK, perhaps after a brief sell-off immediately after the announcement. My stop could be a little too tight here - SEK likes a decent spike as it isn't as liquid as the main pairs - but the H1 price action does look promising - there's enough ammunition in the buyers to break the trendline so even if we reach new lows in the next week before the CB meeting, this is a decent sign buyers are stepping back in. Of course, this trade relies on the idea that USD strength will remain going into the end of December/ 2020. I'm in that camp so I will happily take this trade - but of course, will always on the lookout for the right signs that USD weakness is around the corner (as is widely expected for 2020).
by ForexVox
SEB (SEB_A) | Money-Laundering Concerns! Keep an eye on ~60!Hi, Shares of SEB' AB (Skandinaviska Enskilda Banken AB provides corporate, retail, investment, and private banking services in Sweden and internationally) fell by more than 14% (on Friday) as investors worried that another Nordic bank will be dragged into the scandal over money-laundering. It is hard to say, how the following weeks/months may affect the SEB price (investigations are ongoing) but anyway, I would like to point out a technically strong price level which should play an important role in further price action. Currently, I can only recommend - stay away from it. The price can get more hits during the investigations, especially when these stories get firmer confirmations. To talk about that price level - my eyes are pointed around 60. It needs to fall another ~25% to the mentioned level and definitely, it is doable. I don't want bad but as an investor and trader, I'm looking forward to this level because technically, it is a pretty strong and clean one. Two other major Scandinavian banks, Swedbank and Danske, had already been subject to major investigations in large-scale money laundering activities and I would like to share a comparison with Swedbank, who has already gone through it (almost): As you see, the historical similarities have been pretty amazing. Now, we can take this Swedbank price movement as an example (Swedbank price is the orange line) and it is pointed also to my mentioned "keep-an-eye" level 60. Let's count the other criteria which should act as support levels: 1) Okay, the comparison with Swedbank is pointed to the marked area. 2) 2000/01, 2011 clean resistance levels start to work as a support level. 3) The middle number 60 itself should work as a tiny support level. 4) Channel projection bottom trendline may push the price upwards from the green area. 5) Different Fibonacci Extensions are adding strength to the shown area. 6) Fibonacci retracement 50%. Pulled from 2009 low to 2015 high. 7) AB=CD 8) If the price reaches to the shown area, then it has fallen from the 2015 high at 111.50 to the ~55, which is 50% from the recent high and pretty often stocks make a bounce after they have fallen approximately 50%. So, it matching perfectly with our mentioned area. 9) Obviously, perfect would be a bullish Weekly or Monthly candlestick pattern formation around the green area! Summary: As said, stories around the SEB' stock are serious which makes this stock extremely risky to invest/trade at the current price levels. Be patient, wait for conclusions and if the conclusions are enough for you to be satisfied (after the price has reached ~60) then this could be a perfect spot and timing to invest or reinvest to SEB'. What if it doesn't reach to the mentioned area? Nothing(!), the situation around Nordic banks is highly risky and I search only high-probability investment setups, not the mediocre ones. Mediocre setups can easily damage my success rate, especially under such conditions. If it was helpful then take a second and support my effort by hitting the "LIKE" button, it is my only fee from You! Regards, Vaido
OMXSTO:SEB_A
by VaidoVeek